IVL : Strong IOD Performance Drove 2Q22 Profit to New High
We maintain the BUY call with a new target price of Bt58.0, (6% up from previous, factoring in the 58% upward 2022E earnings revision). The 2Q22...
202 Views
IVL: Solid PET Performance Drove 1Q22 Profit
IVL reported 1Q22 net profit of Bt14.1bn (+134% YoY, +161% QoQ), The result came out better than our expectation and beat the consensus by 95%.
308 Views
IVL: Oxiteno Earnings to Kick in by 2Q22
IVL announced completion of Oxiteno acquisition and consolidation of assets beginning April 2022 (earnings recognition 2Q22 onwards). We have a...
299 Views
IVL: Value Accretion from Oxiteno Acquisition
We have a positive view on IVL’s new acquisition of Oxiteno given the inexpensive deal, earnings accretion and synergy benefits. We maintain the...
172 Views
IVL: Solid Outlook in 2Q21 from Seasonality
We reiterate a BUY rating and upgrade our target price to Bt55.0 (from Bt50), derived from 2.2xPBV’21E which is equal to world material peer.
346 Views